Portfolio

Tubulis

Reimagining Antibody Drug Conju­gates

Tubulis uses proprietary techno­logies to develop novel drugs whose mecha­nisms of operation address the deep-seated causes of the respective disease. The goal is to expand the thera­peutic potential of Antibody Drug Conjugates (ADCs) to enable more targeted and effective treat­ment of cancer and other diseases.

hemotune Overview Code Intelligence